Micro cap Marinus Pharmaceuticals was up 20% premarket this morning on positive, early data from its midstage test of ganaxolone in a rare condition that…

PixarBio has scrapped its bid to buy InVivo Therapeutics “for reasons related to management credibility and competence, corporate governance and IP control.”

As Donald Trump is sworn into office today, we look at what the next 100 days and indeed the next four years could mean for the biopharma industry through his…

The FDA released a pair of draft guidances giving recommendations on how drug and device makers should communicate information about their products.

Cytori Therapeutics is set to gain cancer drugs and a liposomal nanoparticle technology platform through the acquisition of Azaya Therapeutics.

Pfizer has become the latest Big Pharma company to join a consortium that matches drugmakers to researchers in Cambridge, U.K.

Global pharma chief Hussain joins a long list of departing execs at GSK, Merrimack taps Sanofi Genzyme SVP Dr. Richard Peters as CEO, and ex-GSK rare disease…

An international team may have found an alternative approach to managing peripheral neuropathy that could potentially reverse symptoms with a class of drugs…